<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.theedgeresearch.com/news</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>White House looks to FIGHT diesel prices</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/FTC</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>Filtronic shares jump 14% as Cavendish backs outlook after SpaceX order</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/RUCCF</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>Radiant Uranium Outlines Fully Funded Phase 1 &amp; 2 Exploration Program at Cross Lake</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/TEVA</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/LEO</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/PLTR</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>Palantir Remains Our Top Tech Pick Of The 2020s</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/LUNR</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>Intuitive Machines vs. Virgin Galactic: Which Has More Potential?</news:title>
    </news:news>
    <lastmod>2026-10-01</lastmod>
  </url>
</urlset>
